AQA GCSE Biology Biology Paper 1 (Higher), June 2025: Question 7

17 marks · Standard Demand difficulty · Extended Answer

Explain treatments for severe liver disease including stem cells, monoclonal antibody production to prevent rejection, and the role of bile in fat digestion.

Practise this question

Question

Exam question 7 detailing treatments for severe liver disease. Parts 07.1 and 07.2 ask about properties and ethical concerns of using embryonic stem cells. Figure 9 illustrates the production of monoclonal antibodies, showing a mouse, Cell type A fusing with Cell type B to form Cell type C. Parts 07.3 to 07.6 ask to identify these cells, how the mouse is stimulated, how antibodies prevent transplant rejection, and other antibody uses. Part 07.7 asks where bile is stored with a multiple-choice tick box. Part 07.8 is an extended 6-mark question asking to explain why liver disease causes difficulty in digesting fats.
Question text

07 In people with severe liver disease the liver stops working correctly.

A person with severe liver disease can be treated with:

• an injection of embryonic stem cells

or

• a liver transplant from a donor.

The person’s body can reject embryonic stem cells and can reject a liver transplanted

from a donor.

07.1 What property of embryonic stem cells makes them suitable to treat liver disease?

[1 mark]

07.2 Suggest one ethical reason why a person may not want an injection of embryonic

stem cells.

[1 mark]

Drugs can be used to reduce the risk of liver rejection after a transplant.

One drug contains monoclonal antibodies.

The monoclonal antibodies are specific to an antigen on the surface of liver cells.

Figure 9 shows part of the process used to create the monoclonal antibodies.

Figure 9

07.3 Name the three types of cell in Figure 9.

[3 marks]

A

B

C 31

07.4 How is the mouse stimulated to produce cell type A?

[1 mark]

07.5 A patient with severe liver disease was given a liver transplant.

The drug containing the monoclonal antibody is given to the patient.

Explain how the monoclonal antibody stops the patient’s white blood cells from

attacking the cells of the donor liver.

[3 marks]

07.6 Give one other use of monoclonal antibodies.

Do not refer to pregnancy tests.

[1 mark]

The liver produces bile.

Bile is needed for efficient digestion.

07.7 Where is bile stored in the human body?

[1 mark]

Tick ( ) one box.

Gall bladder

Kidney

Pancreas

Small intestine

07.8 Explain why a person with severe liver disease has difficulty digesting fats.

[6 marks]

Mark scheme

Show the mark scheme Mark scheme for Question 7 totalling 17 marks. Outlines accepted answers: differentiation into any cell type for 07.1; ethical concerns regarding embryo destruction or consent for 07.2; lymphocyte, tumour/myeloma cell, and hybridoma for 07.3; injection with antigens for 07.4; binding to liver antigens to block host white blood cells for 07.5; diagnostic or therapeutic uses for 07.6; gall bladder for 07.7; and a 3-level mark scheme for 07.8 covering lack of bile, failure to emulsify fats/increase surface area, and failure to neutralise acid to provide optimum pH for lipase.

Question 7

AO /

Question Answers Extra information Mark

Spec Ref.

07.1 (stem cells) can differentiate into allow (stem cells) can 1 AO1

any type of cell differentiate into liver cells 4.1.3.2

ignore specialisation

AO /

Spec Ref.

07.2 any one from: 1 AO2

4.1.3.2

• (it is) destroying a (potential)

life / embryo

• embryo cannot give consent allow the embryo does not have

a choice

• (against) religious / cultural / allow against (someone’s) faith

personal beliefs ignore against God’s will

ignore religion unqualified

AO /

Spec Ref.

07.3 A = lymphocyte (specific to the ignore white blood cell 1 AO2

antigen) 4.3.2.1

B = tumour (cell) allow myeloma 1

allow other specific types of

tumour (cell)

ignore cancer (cell)

C = hybridoma 1

AO /

Spec Ref.

07.4 (the mouse is) injected with allow (by) injecting (the mouse) 1 AO2

(liver) antigens with liver cells 4.3.2.1

do not accept (by) injecting (the

mouse) with a pathogen

AO /

Spec Ref.

07.5 monoclonal antibodies bind to allow drug sticks to (liver) 1 AO2

(liver) antigens / cells antigens / cells 4.2.2.3

4.3.1.6

(because) monoclonal allow description of 1 4.3.2.1

antibodies are complementary complementarity 4.3.3.2

(in shape) to (liver) antigen ignore reference to specificity

do not accept (because)

monoclonal antibodies are the

same shape as (liver) antigen

(so) antibodies released by allow (so) antibodies released

white blood cells cannot bind to by lymphocytes cannot bind to

(liver) antigens / cells (liver) antigens / cells

allow (so) phagocytes are

unable to identify / detect cells

to engulf

do not accept (so) antibodies

released by phagocytes cannot

bind to liver antigens / cells

AO /

Spec Ref.

07.6 any one from: 1 AO1

• tests to detect pathogens allow COVID tests or lateral flow 4.3.2.2

tests or LFTs

• tests to detect hormones /

chemicals / drugs

• to locate / identify (specific)

molecules in a cell / tissue

• to locate / detect cancer

(cells)

• to deliver (toxic) chemicals / allow chemotherapy /

drugs to cells immunotherapy

allow to treat named disease

ignore to diagnose / treat

disease unqualified

AO /

Spec Ref.

07.7 gall bladder 1 AO1

4.2.2.1

AO /

Question Answers Mark

Spec Ref.

26 07.8 Level 3: Relevant points (reasons / causes) are identified, given in 5-6 AO2

detail and logically linked to form a clear account.

Level 2: Relevant points (reasons / causes) are identified, and 3-4 AO1

there are attempts at logical linking. The resulting account is not

fully clear.

Level 1: Points are identified and stated simply, but their relevance 1-2 AO1

is not clear and there is no attempt at logical linking.

No relevant content. 0 4.2.2.1

Indicative content

• less / no bile produced (by liver) so less / no emulsification of fats

o (so) fats not made into small(er) droplets

o (so) surface area (of fat) not increased

o (so) lipase cannot digest fat as quickly / much (due to smaller

surface area)

• less / no bile produced (by liver) so acid not neutralised

o (because) bile is alkaline

o (so) lipase or small intestine not at optimum pH

o (so) lipase denatures

o (so) lipase cannot digest fat as quickly / much (due to reduced

/ incorrect pH)

For Level 3, there must be consideration of the effect on lipase

activity and on both emulsification and the effects of pH.

Total Question 7 17

How to answer it

Liver Disease: Stem Cells, Monoclonal Antibodies & Digestion

📋 What this question tests

This 17-mark question assesses three fundamental AQA GCSE Biology specifications:

  • Cell Biology: Potency and ethical considerations of human embryonic stem cells.
  • Infection and Response: Step-by-step production of monoclonal antibodies (hybridoma formation) and their clinical applications.
  • Organisation & Digestive System: The dual role of bile (neutralisation and emulsification) and its vital link to lipase activity.

Parts 07.1 & 07.2: Embryonic Stem Cells

Potency and Ethical Implications

✅ Model Answers

07.1: Stem cells can differentiate into any type of cell (or can differentiate into liver cells). 1 mark

07.2: Any one ethical reason: 1 mark

  • Using an embryo destroys a (potential) human life.
  • The embryo cannot give consent or make a choice.
  • It goes against religious, cultural, or personal beliefs.

💡 Key Knowledge

Embryonic stem cells: Pluripotent cells derived from early-stage embryos. Unlike adult stem cells (e.g. from bone marrow, which can only form blood cells), embryonic stem cells can specialise into all cell types in the body.

🧠 Exam Technique

  • Always use the scientific term differentiate rather than loose terms like "change into" or "grow into".
  • For ethical questions, be clear and specific. Mentioning that the "embryo is destroyed" or "cannot consent" directly meets marking criteria.

❌ Common Errors

  • Vague words like "specialisation" alone without explaining they can turn into any cell type.
  • Writing simply "against religion" without specifying that it is against someone's faith/beliefs regarding the destruction of life.
Examiner Insight: In 07.1, the mark scheme specifically says to ignore specialisation on its own. You must mention differentiation into any cell or into liver cells.

Parts 07.3 & 07.4: Monoclonal Antibody Production

Figure 9 Diagram & Stimulation

✅ Model Answers

07.3: Cell Types in Figure 9 3 marks

  • A: Lymphocyte (or spleen cell / B-cell) [1]
  • B: Tumour cell (or myeloma cell) [1]
  • C: Hybridoma cell [1]

07.4: How mouse is stimulated 1 mark

The mouse is injected with (liver) antigens (or injected with donor liver cells).

💡 Key Knowledge

To make monoclonal antibodies:

  1. Inject mouse with target antigen.
  2. Mouse B-lymphocytes produce antibodies but cannot divide.
  3. Fuse lymphocyte with a tumour cell (which divides indefinitely) to create a hybridoma.
  4. Clone the hybridoma to mass-produce identical (monoclonal) antibodies.

❌ Common Errors

  • Writing "white blood cell" instead of lymphocyte for Cell A (rejected by mark scheme).
  • Calling Cell B simply "cancer" rather than tumour cell or myeloma.
  • In 07.4, stating the mouse is injected with a "pathogen" or "disease". The question specifies liver transplant rejection, so it is stimulated with liver antigens.
Examiner Insight: Cell C is formed by the fusion of Cell A and Cell B. The resulting cell is uniquely named a hybridoma.

Parts 07.5 & 07.6: Mechanism of Action & Uses

Preventing Rejection & Diagnostic Applications

✅ Model Answers

07.5: Preventing attack by white blood cells 3 marks

  1. Monoclonal antibodies bind to (liver) antigens / cells [1].
  2. Because monoclonal antibodies are complementary in shape to the (liver) antigen [1].
  3. So antibodies released by the patient's white blood cells cannot bind to the liver antigens (or phagocytes cannot detect/engulf the cells) [1].

07.6: One other use 1 mark

Any one from: Detect pathogens (e.g. lateral flow tests) / locate specific molecules in cells / deliver drugs or radioactive substances to cancer cells.

🧠 Exam Technique: "Explain how" (3 marks)

Notice the 3-step causal chain required for 07.5:

Binding → Reason (Complementary Shape) → Result (Blockade).

Always mention why they bind: their binding sites have a complementary shape to the specific antigens.

❌ Common Errors

  • Saying antibodies have the "same shape" as antigens. They are complementary (fit together like lock and key).
  • In 07.6, mentioning pregnancy tests when the question explicitly states: "Do not refer to pregnancy tests." Always read exclusions!
  • Saying "to treat disease" without qualification. State how (e.g., deliver chemotherapy drugs to cancer cells).

Parts 07.7 & 07.8: Bile & Fat Digestion

Extended 6-Mark Explanation

✅ Part 07.7 Model Answer

Where is bile stored in the human body? 1 mark

☑ Gall bladder (Produced in the liver, stored in the gall bladder, released into the small intestine).

📐 Part 07.8: Building a 6/6 Answer

To achieve Level 3 (5–6 marks), you must link two distinct pathways: Emulsification AND pH / Neutralisation, showing their direct effect on lipase.

Path 1: Emulsification (Surface Area)

  1. Severe liver disease means less or no bile is produced.
  2. Without bile, large lipid droplets are not emulsified into small droplets.
  3. This means the surface area of the fat is not increased.
  4. Therefore, lipase enzymes break down fats much more slowly.

Path 2: Neutralisation (Optimum pH)

  1. Bile is alkaline and neutralises hydrochloric acid from the stomach.
  2. With less bile, stomach acid is not properly neutralised.
  3. The pH in the small intestine remains acidic and is not at the optimum pH for lipase.
  4. Lipase enzymes can denature (active site changes shape) or work at a drastically lower rate.

🧠 Examiner Level Breakdown

  • Level 3 (5–6 marks): Both pathways covered clearly. Specifically mentions lipase activity, emulsification, and pH/acid neutralisation.
  • Level 2 (3–4 marks): Mentions both emulsification and neutralisation, but fails to fully link both to lipase activity.
  • Level 1 (1–2 marks): Isolated facts (e.g. "bile is made in liver", "fats need lipase") with no logical sequence.

❌ Crucial Pitfalls

  • Bile is NOT an enzyme: Never say "bile digests fat" or "bile breaks down fat into fatty acids". Bile only physically emulsifies fat. Lipase performs the chemical digestion.
  • Saying enzymes "die": Enzymes are molecules, not living things. They denature.
Summary of Key Chemical Reaction:
Lipids (Fats) + Lipase → Glycerol + Fatty Acids (Works best in alkaline conditions provided by bile!)

Topics

Biology · B1: Cell Biology · B2: Organisation · B3: Infection and Response

Question and mark scheme from the AQA GCSE Biology examination, Biology Paper 1 (Higher), June 2025. QuestionVault is an independent revision resource; questions remain the copyright of the awarding body.